TARGETING THE EGFR/HER FAMILY IN BREAST AND GASTRIC CANCERS
More potent HER-2 inhibition: New EGFR/HER family-directed strategies
J. Cortés
More potent HER-2 inhibition: New EGFR/HER family-directed strategies
J. Cortés